Innovassynth Investments Limited at Board Meeting held on December 23, 2025, has considered and approved the appointment of Mr. Prosenjit Gupta, the Director of the Company having as Chairperson of the Board of Directors of the Company with immediate effect and shall remain as Chairperson unless otherwise decided by the Board. The Board has considered and approved the appointment of Dr. Hardik Joshipura (DIN: 0939251) as a Chief Executive officer, pursuant to recommendation of the Nomination and Remuneration Committee held on December 23, 2025. Dr. Hardik Joshipura shall continue to serve as the Managing Director of the Company, and his designation shall henceforth be "Managing Director & Chief Executive Officer (MD & CEO)".
Dr. Hardik Joshipura serves as the Managing Director of the company. Before joining Innovassynth, he held various senior leadership positions at Sigma-Aldrich and later at Merck KGaA, gaining extensive experience in manufacturing, sales, and global strategic marketing. Dr. Joshipura began his career at Zydus Cadila, where he led Contract Research R&D for the Fine Chemicals business.
He holds a Ph.D. in Organic Chemistry and is an alumnus of Harvard Business School (HBS), Boston, USA, where he completed Executive MBA.
